RNAi, vielversprechendes Potenzial für eine neue Klasse von Medikamenten
Alnylam Overview
Alnylam Accepted the Red Tie Challenge
Roland und Nicky (Deutschland) - Leben mit hATTR
John Maraganore, Ph.D., Chief Executive Officer, Alnylam Pharmaceuticals, Inc. at BIO 2017
Boston Globe Top Places to Work 2017!
From Possibility to Patients: The Scientific Odyssey - The Dark Ages
Barry Greene, Alnylam Pharmaceuticals - 2020 PharmaVOICE 100
Die PH1-Geschichte von Stephanie und Jörg
Helping Hands - Community Service Day 2019
Sophia's experience living with hATTR amyloidosis
Top 10 Biotech Companies in the World
City with the lowest tax rates | schnapps capital | Switzerland
2020 Future of Manufacturing - Olivier de Weck
Wallstreet außer Rand und Band, Moderna, Albemarle, Zalando, Bayer, China-Jürgen baut etwas Cash auf
Update on Clinical Trials
Aktien: 3 heiße Eisen! Diese Aktien haben’s in sich!
Martin Graham & Ron Newbold of the Empire Discovery Institute on NewYorkBIOs VirtualBreakfast Series
A view into investing with technologists, biotech venture capitalists and biopharma innovators
What'd You Miss in Markets Today? Here's Your Recap (10/06/16)
